These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26360500)

  • 1. Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.
    Galling B; Calsina Ferrer A; Abi Zeid Daou M; Sangroula D; Hagi K; Correll CU
    Expert Opin Drug Saf; 2015 Oct; 14(10):1587-608. PubMed ID: 26360500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis.
    Galling B; Garcia MA; Osuchukwu U; Hagi K; Correll CU
    Expert Opin Drug Saf; 2015 Aug; 14(8):1181-99. PubMed ID: 26107820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.
    Galling B; Roldán A; Rietschel L; Hagi K; Walyzada F; Zheng W; Cao XL; Xiang YT; Kane JM; Correll CU
    Expert Opin Drug Saf; 2016 May; 15(5):591-612. PubMed ID: 26967126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):149-161. PubMed ID: 27318835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2012 Apr; 66(4):356-68. PubMed ID: 22284853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis.
    Rocha FL; Fuzikawa C; Riera R; Hara C
    J Clin Psychopharmacol; 2012 Apr; 32(2):278-81. PubMed ID: 22367652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis.
    Meeker AS; Herink MC; Haxby DG; Hartung DM
    Syst Rev; 2015 Mar; 4():21. PubMed ID: 25874839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
    Lao KS; He Y; Wong IC; Besag FM; Chan EW
    CNS Drugs; 2016 Nov; 30(11):1043-1054. PubMed ID: 27550371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Korean Medication Algorithm for Depressive Disorder: second revision.
    Seok Seo J; Rim Song H; Bin Lee H; Park YM; Hong JW; Kim W; Wang HR; Lim ES; Jeong JH; Jon DI; Joon Min K; Sup Woo Y; Bahk WM
    J Affect Disord; 2014; 167():312-21. PubMed ID: 25010375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.
    Nelson JC; Baumann P; Delucchi K; Joffe R; Katona C
    J Affect Disord; 2014 Oct; 168():269-75. PubMed ID: 25069082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia.
    Kishi T; Iwata N
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):343-54. PubMed ID: 23823741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2013 Nov; 67(11):1089-104. PubMed ID: 24016209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of St. John's wort for major depressive disorder.
    Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
    Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review.
    Sinyor M; Cheung CP; Abraha HY; Lanctôt KL; Saleem M; Liu CS; Li A; Juda A; Levitt AJ; Cheung AH; Schaffer A
    J Affect Disord; 2020 Apr; 267():185-190. PubMed ID: 32217218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
    Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wuling Capsule for Major Depressive Disorder: A Meta-analysis of Randomised Controlled Trials.
    Zheng W; Zhang YF; Zhong HQ; Mai SM; Yang XH; Xiang YT
    East Asian Arch Psychiatry; 2016 Sep; 26(3):87-97. PubMed ID: 27703096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.